Andrew W. Stoker

Institute of Child Health — Greece

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index2.8kcitations96works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Tyrosine Phosphatases(40), Axon Guidance and Neuronal Signaling(21), Virus-based gene therapy research(13), Neuroblastoma Research and Treatments(11), Galectins and Cancer Biology(9)

Publications95 total

HMMR has oncoprotein-like properties in neuroblastoma cells and high HMMR expression has independent prognostic potential in neuroblastomas
Scientific Reports·2025Open Access
HMMR is an independent prognostic indicator in neuroblastoma and loss of HMMR suppresses cell proliferation, migration and clonogenicity.
2024Open Access
The cytotoxic action of BCI is not dependent on its stated DUSP1 or DUSP6 targets in neuroblastoma cells
FEBS Open Bio·2022· 14 citedOpen Access
Integrin‐Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor‐Specific Delivery Achieve <i>MYCN</i> Silencing with Improved Survival
Advanced Functional Materials·2021· 18 citedOpen Access
A Review of DUSP26: Structure, Regulation and Relevance in Human Disease
International Journal of Molecular Sciences·2021· 28 citedOpen Access
Characterising the Role of Hyaluronic Acid Receptor ‘HMMR’ in Regulating Neuroblastoma Cell Growth and Survival
European Journal of Surgical Oncology·2020
The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cells
Scientific Reports·2020· 10 citedOpen Access
<i>MYCN</i> Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid
Nucleic Acid Therapeutics·2020· 15 citedOpen Access
Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells
Journal of drug targeting·2020· 4 citedOpen Access
Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells
Figshare·2020Open Access
P565 Validation of novel growth-promoting and growth-suppressing genes in neuroblastoma cells
Abstracts·2019Open Access
G552(P) Validation of novel growth-promoting and growth-suppressing genes in neuroblastoma cells
2019
Author Index
Molecular Syndromology·2019Open Access
Title Page / Table of Contents
Molecular Syndromology·2019Open Access
An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis
Molecular Syndromology·2018· 18 citedOpen Access
Supplementary Material for: An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis
Figshare·2018Open Access
Vanadium Compounds as PTP Inhibitors
Molecules·2017· 120 citedOpen Access
588. MYCN Silencing Using RNA Interference Causes Apoptosis and Differentiation in MYCN Amplified Neuroblastoma Cell Lines
Molecular Therapy·2016Open Access
RPTPs and Cancer
2016· 1 cited
Detection and Identification of Ligands for Mammalian RPTP Extracellular Domains
Methods in molecular biology·2016· 2 cited
page 1 of 5Next →

Frequent Co-authors

Mina J. Bissell(6), A.R. Aricescu(5), Iain W. McKinnell(5), Fawaz G. Haj(4), J A Wyke(4), Wiljan Hendriks(3), John L. Bixby(3), Muhamed Hawadle(3), Daniel Alete(3), John K. Chilton(3), Gustavo Sajnani(3), Ruhina Maeshima(3), Ari Elson(2), Sheila Harroch(2), Rafael Pulido(2), E. Yvonne Jones(2), Matthias M. Ledig(2), Bernhard K. Mueller(2), Bernhard Gehrig(2), Boon‐Huat Bay(2)